Skip to main content
. 2019 Nov 14;13:3867–3877. doi: 10.2147/DDDT.S212235

Table 3.

Reproductive Outcomes After FET According To The Type Of Endometrial Preparation Treatments

Characteristics Letrozole (n=1569) HMG (n=1827) Letrozole+HMG (n=2505) P-Valuea P-Valueb P-Valuec
Number of FET 1569 1827 2505
Number of thawed embryos 3022 3476 4715
Number of viable embryos after thawed 2986 3441 4687
Developmental stage at cryopreservation
Cleavage stage (Day 3 or 4) 2619(87.71%) 3043(88.42%) 2203(87.93%) 0.196 0.295 0.412
Blastocyst stage (Day 5) 367(12.29%) 398(11.58%) 302(12.07%)
Embryo quality
Grade I 649(21.73%) 690(20.06%) 523(20.86%) 0.245 0.076 0.091
Grade II 2332(78.09%) 2746(79.79%) 1970(78.66%)
Grade III 5(0.18%) 5(0.15%) 12(0.48%)
Number of embryos transferred
1 194(6.49%) 221(6.42%) 285(6.08%) 0.472 0.279 0.246
2 2792(93.51%) 3220(93.58) 4402(99.92%)
Clinical pregnancy rate per transfer (%) 52.07% (817/1569) 47.02% (859/1827) 52.26% (1309/2505) 0.047 0.037 0.486
Implantation rate (%) 34.36% (1026/2986) 31.76% (1086/3441) 34.24% (1605/4687) 0.048 0.036 0.481
Miscarriage rate (%) 10.53% (86/817) 14.78% (127/859) 14.13% (185/1309) 0.013 0.381 0.018
Multiple pregnancy rate (%) 25.58% (209/817) 26.43% (227/859) 22.61% (296/1309) 0.402 0.063 0.121
Ectopic pregnancy rate (%) 0.97% (5/833) 1.83% (16/875) 1.58% (21/1330) 0.018 0.392 0.031
Intrauterine and ectopic pregnancy rate (%) 0.36% (3/833) 0.80%(7/875) 0.38% (5/1330) 0.194 0.161 0.629
Ongoing pregnant rate per transfer (%) 47.61% (747/1569) 41.32%(755/1827) 47.27% (1184/2505) 0.012 0.009 0.461
Live birth rate (%) 46.59% (731/1569) 39.96%(730/1827) 44.87% (1124/2505) 0.008 0.022 0.265

Notes: aLetrozole vs HMG; bHMG vs letrozole+HMG; cLetrozole vs letrozole+HMG. Bold values represent statistical significance.